title: FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
authors.affiliation: INSERM, IFR, Oullins, France.
authors.forename: Amélie
authors.initials: A
authors.lastname: Bravard
authors.forename: Etienne
authors.initials: E
authors.lastname: Lefai
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Meugnier
authors.forename: Sandra
authors.initials: S
authors.lastname: Pesenti
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Disse
authors.forename: Julien
authors.initials: J
authors.lastname: Vouillarmet
authors.forename: Nöel
authors.initials: N
authors.lastname: Peretti
authors.forename: Rémi
authors.initials: R
authors.lastname: Rabasa-Lhoret
authors.forename: Martine
authors.initials: M
authors.lastname: Laville
authors.forename: Hubert
authors.initials: H
authors.lastname: Vidal
authors.forename: Jennifer
authors.initials: J
authors.lastname: Rieusset